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Abstract
Background:  W e  u n d e r t o o k  a  s y s t e m a t i c  r e v i e w  o f  observational studies of depression in
primary care to determine 1) the nature and scope of the published studies 2) the methodological
quality of the studies; 3) the identified recovery and risk factors for persistent depression and 3)
the treatment and health service use patterns among patients.
Methods: Searches were conducted in MEDLINE, CINAHL and PsycINFO using combinations of
topic and keywords, and Medical Subject Headings in MEDLINE, Headings in CINAHL and
descriptors in PsycINFO. Searches were limited to adult populations and articles published in
English during 1985–2006.
Results: 40 articles from 17 observational cohort studies were identified, most were undertaken
in the US or Europe. Studies varied widely in aims and methods making it difficult to meaningfully
compare the results. Methodological limitations were common including: selection bias of patients
and physicians; small sample sizes (range 35–108 patients at baseline and 20–59 patients at follow-
up); and short follow-up times limiting the extent to which these studies can be used to inform our
understanding of recovery and relapse among primary care patients with depression. Risk factors
for the persistence of depression identified in this review were: severity and chronicity of the
depressive episode, the presence of suicidal thoughts, antidepressant use, poorer self-reported
quality of life, lower self-reported social support, experiencing key life events, lower education level
and unemployment.
Conclusion: Despite the growing interest in depression being managed as a chronic illness, this
review identified only 17 observational studies of depression in primary care, most of which have
included small sample sizes and been relatively short-term. Future research should be large enough
to investigate risk factors for chronicity and relapse, and should be conducted over a longer time
frame.
Background
A recent World Health Organization report states that
depression is the leading cause of disability worldwide
among people aged five and above [1]. People with
depression are mainly managed in primary care/general
practice [2], yet current management guidelines are
mainly based upon data collected in the secondary and
tertiary sectors. Studies of relapse rates, risk factors for
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relapse and efficacy of maintenance therapy have been
conducted mainly in tertiary psychiatric settings [3], with
a paucity of data from primary care [4,5].
In preparing for an observational study of the health serv-
ice use and treatment patterns of Australians experiencing
depressive symptoms [6] we undertook a systematic
review of observational studies of depression in primary
care to determine 1) the nature and scope of the published
studies 2) the methodological quality of the studies; 3)
the identified recovery and risk factors for persistent
depression and 3) the treatment and health service use
patterns among patients.
Methods
Selection and inclusion criteria
We selected prospective observational studies where pri-
mary care patients were screened for depression and fol-
lowed over time. Articles were assessed as relevant by both
authors. We identified three review articles that described
the prevalence and course of depression in primary care
[4,5,7], relevant studies from these reviews published dur-
ing 1985–2006 are included in the current review.
Exclusion criteria
As the purpose of this review was to examine naturalistic
studies receiving routine care, subjects recruited as part of
a randomised controlled trial were excluded to reduce
bias from selecting patients consenting to participate in
intervention or medication trials. It was considered that
these patients may not be representative of patients in
general practice, as research has found that many primary
care patients prefer psychological treatments [8] and
therefore may be less likely to enter antidepressant treat-
ment or randomized clinical trials as a result [9]. It has
also been shown that subjects in randomised trials have
better care and outcomes than 'routine care'. Articles were
excluded for the following reasons: patients were origi-
nally recruited as part of a randomised controlled trial (n
= 11) [3,10-19] or an intervention study (n = 1) [20]; ret-
rospective analyses of administrative or clinical data were
used (n = 6) [21-26]; retrospective life charts were used to
gain longitudinal data (n = 1) [27]; only primary care
patients initiating antidepressant treatment were recruited
(n = 2) [28,29]; patients selected were 'psychiatric cases'
and results were not presented for depression (n = 2)
[30,31]; and review articles (n = 1) [5].
Search strategy
An Information Consultant at The University of Mel-
bourne assisted with the development of the search strat-
egy. Searches were conducted separately for each of the
following databases: MEDLINE, CINAHL and PsycINFO.
Search strategies were devised using combinations of
topic and keywords, and Medical Subject Headings
(MeSH) in MEDLINE, Headings in CINAHL and descrip-
tors in PsycINFO. Searches were limited to adult popula-
tions and articles published in English during 1985–
2006. Figure 1 describes the search statements conducted
in each of the three databases searched. Further relevant
articles were sourced through cross checking references in
articles and from the authors' library.
Results
The abstracts of 432 articles identified using the search
strategy described above were considered (Figure 2). Fifty-
one potentially relevant articles were retrieved for compre-
hensive review. Twenty four articles were excluded as they
did not meet criteria for an observational study of depres-
sion (see exclusion criteria). Forty articles from 17 obser-
vational prospective cohort studies were identified, 27
articles from the original search [32-58] and 13 from sec-
ondary references [59-71].
Search strategies limited to articles published in English during 1985–2006 and adult populations Figure 1
Search strategies limited to articles published in English during 1985–2006 and adult populations.
MEDLINE CINAHL PsycINFO   
MeSH Heading=(Depression OR 
Depressive Disorder, Major OR 
Depressive Disorder OR 
Topic=depress*) AND MeSH 
Heading=(Family Practice OR 
Physicians, Family or Primary Health 
Care OR Topic=general practice*) 
AND MeSH Heading=(Longitudinal 
Studies OR Cohort Studies OR Follow-
up Studies)  
(Heading “Depression”) and ((Heading 
“Family Practice”) OR (Heading 
“Physicians, Family) OR (Heading 
“Primary Health Care”)) AND (Heading 
“Prospective Studies””)
1
Descriptor=(major depression or 
depression emotion or depression or 
depressive disorder* or depress*) AND 
Descriptor=(general practitioners or 
family medicine or family physicians or 
primary health care) 
Methodology was limited to Followup 
Study or Longitudinal Study or 
Prospective Study
1 In CINAHL Prospective Studies is used for: Cohort Studies; Follow-up Studies; Incidence Studies and Longitudinal StudiesBMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
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Methods used
Table 1 describes the methods for the 17 longitudinal
studies included in the review. The studies varied widely
in their original purpose. The studies can be grouped into
those that focused on depressive symptoms (n = 7)
[45,51,54,61,63,66,68] and those that focused on major
depressive disorder satisfying DSM IV criteria (n = 10)
[37,38,43,44,48,49,59,64,67,69]. Nine of the 17 studies
Flowchart of articles included in the review Figure 2
Flowchart of articles included in the review.
Additional articles from 
secondary references 
n=13
Articles included in the 
systematic review 
n=27
Articles excluded*
n=24
*patients were originally recruited as part of a 
randomised controlled trial (n=11); a pre-post test 
study on the effect of postgraduate training on 
process of care and patient outcomes (n=1); 
retrospective analyses of administrative or clinical 
data were used (n=6); retrospective life charts were 
used to gain longitudinal data (n=1);  pharmacy 
records were used to identify a cohort of primary 
care patients initiating antidepressant treatment (n 
=1); participants selected were ‘psychiatric cases’ 
and results not presented for depression (n=2); 
participants were diagnosed with depression by 
GPs and were being prescribed antidepressants 
(n=1) & review articles (n=1)
Abstracts of articles 
reviewed
n=432
Articles considered 
potentially relevant and 
reviewed
n=51
Number of observational 
longitudinal studies of 
depression in general practice
n=17
Multi
country
studies
n=2
Studies
conducted
in US 
n=8
Studies
conducted
in Europe
n=5
Studies
conducted in 
Australia
n=1
Studies
conducted in 
New Zealand
n=1BMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
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aimed to describe the course of depression over time and
identify risk factors associated with recovery or improve-
ment in depression [37,43,44,54,61,63,64,68,69]. Four
studies were interested in examining detection of depres-
sion by the practitioner and depression outcome
[38,49,64,66]. One study examined the seasonality preva-
lence and incidence of depressive disorder [59], one
examined the process and outcomes of rural depression
care [67], one examined the outcomes for cases 'missed' at
the screening encounter [45], one examined the preva-
lence of bipolar II disorder with depressive and anxiety
subtypes [48], and one examined whether managed care
was associated with reduced access to mental health spe-
cialists and poorer outcomes among patients with depres-
sive symptoms [51].
Studies varied widely in methods; including the screening
and assessment instruments used, eligibility for inclusion
in the cohort and the length of follow-up (Table 1).
Cohort sizes ranged from 35 [68] to 1336 [51] patients.
Follow-up ranged from 20 weeks [68] to 3.5 years [64].
The majority of the studies followed patients for 12
months, with nine studies following patients for less than
12 months (range 20 weeks to 9 months)
[37,43,48,49,51,61,66-68] (Table 1).
Setting
Most studies were undertaken in the US or Europe (Figure
2). The review also includes two multi-country studies:
the Longitudinal Investigation of Depression Outcomes
in primary care (LIDO) [44] and the World Health Organ-
ization (WHO) Collaborative Project on Psychological
Problems in General Health Care [69]. Several of the
study sites (Netherlands [55], Italy [36] and US [57,71])
involved in the multi countries WHO Collaborative
Project on Psychological Problems in General Health Care
have published results independently. The individual
results are presented from these sites alongside the cumu-
lative results from the WHO Collaborative Project on Psy-
chological Problems in General Health Care in Table 2.
Selection procedures
Consecutive and convenience sampling methods were
used in the majority of studies. No study recruited a ran-
dom sample of patients from primary care. Only six stud-
ies detailed how the settings or clinicians were selected:
GPs were randomly selected in two studies [43,63]; set-
tings were selected in two studies based on research expe-
rience and capacity, and on previous collaboration
[44,69]; GPs were a representative sample from the total
population of GPs in the area in one study [64] and in
another, GPs were a consenting sub-sample from a larger
study on physician referral [51]. Those remaining were
conducted on convenience samples selected from health
centres [59]; general practices or family practice clinics
[37,45,48,54,66,68], with rural practices [67], from fam-
ily physicians and a University Psychiatry Outpatient
Department [49] or in multi-specialty clinics that had
mental health care services, outpatient services, day care
and inpatient services [61]. Using statewide telephone
screening, one study identified and followed a cohort
with a current major depression who made one or more
visits to a primary care physician during the six months
following baseline [38].
Inclusion criteria
Six studies included only patients with major depression
[38,43,44,49,59,67], three studies included patients with
depressive symptoms [51,66,68], two studies included
patients with depression or anxiety disorders or symp-
toms [37,48] and one included 'new' (i.e. a psychiatric
diagnosis had not been diagnosed during the 12 months
prior to the index visit) and 'old' (i.e. a psychiatric diagno-
sis had been diagnosed during the 12 months prior to the
index visit) patients with depression and anxiety disor-
ders, including borderline disorders and non-specific psy-
chiatric symptoms [35]. Of the remaining five studies,
four included patients with depressive symptoms and
asymptomatic patients in the follow-up [45,54,61,63]
and one included patients with current psychiatric disor-
der and a random sample of patients without a current
psychiatric disorder in the follow-up [69]. Two studies
excluded patients who had received recent treatment for
depression; one in the previous three months [44] and
one where patients had contact with the clinic where the
research was being conducted in the six months prior to
the study [66]. One study included only non-referred
patients presenting with anxiety or depression [48]. One
study screened people for depression from random
households using state-wide telephone lists and presented
follow-up data on those who had visited a general practi-
tioner in the six months following baseline interview [38].
Screening procedures
Seventeen different instruments were used at baseline to
measure depressive symptoms or disorders. The Center
for Epidemiologic Studies-Depression Scale (CES-D) [72]
and various versions of the General Health Questionnaire
(GHQ) [73] were the most commonly used screening
instruments (Table 1).
Comorbidity measures
The majority of studies also measured co-morbid psychi-
atric symptoms or disorders, mainly anxiety related. Only
six examined physical co-morbidities or days out of role
[38,44,48,54,67,69]. Grembowski et al. [51] reported
measuring 21 co-morbid conditions, however these con-
ditions were not reported.B
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) Table 1: Methods
Author Blacker et al. [59] Grembowski 
et al. [51]
Groningen 
Primary 
Care Study 
[32-
35,50,64,65]
Kessler et al. 
[61]
Kessler et al. 
[45,60]
Limosin et al. 
[43]
Longitudinal investigation of 
depression outcomes in primary care 
(LIDO) [39,40, 44,52,62]
Mental Health & General Practice 
Investigation (MaGPie) [63]
Manning et 
al. [48]
Location England US Netherlands US England France Israel, Brazil, Spain, Australia, Russia, US New Zealand US
Primary care 
setting/s
One health centre 261 primary 
physicians in 
private 
practice from 
72 offices
25 General 
Practitioners
A multi-
specialty 
group practice 
with 175 
physicians
One general 
practice
560 General 
Practitioners
6 research sites Primary care & outpatient 
services, day care services, & inpatient 
hospital services
70 General Practitioners One private 
ambulatory 
family practice 
centre
Selection of 
primary care 
setting
Not stated Consenting 
GPs from 
Physician 
Referral Study
Representativ
e sample
Not stated Not stated Randomly selected Track record of international collaborative 
research
Randomly selected Not stated
Recruitment Consecutive patients Waiting room Consecutive 
patients
Patients who 
used clinic
Consecutive 
patients
Each GP enrolled 
first patient to meet 
criteria for major 
depressive episode
Patients attending primary care facilities All adult attenders Consecutive 
non-referred 
patients 
presenting 
with 
impairment 
due to 
depression or 
anxiety
Screen for 
depression/
mental 
health
General Health 
Questionnaire 
(GHQ)-30, Schedule 
for Affective 
Disorders and 
Schizophrenia 
(SADS)
Symptom 
Checklist 
(SCL) -20
GHQ-30 & 
rated by GP 
for current 
mental health 
problem
GHQ-30 GHQ-12 Structured Clinical 
Interview for DSM 
(SCID)
Center for Epidemiologic Studies-
Depression Scale (CES-D)
GHQ-12 5 question 
screening 
instrument
Exclusion 
criteria
Not stated <18 years, non 
English 
speaking
Not stated Not stated Not stated <18 years Recent treatment for depression; psychoses; 
dementia; any other condition would 
interfere with the study objectives
< 18 years, not able to read English & 
consulting with GP other than index GP
Not stated
Criteria for 
inclusion in 
cohort
Depressive 
disorders
Depressive 
symptoms
Three or 
more 
psychiatric 
symptoms on 
PSE
192 patients 
with GHQ-30 
scores = 4 & 
55 with lower 
scores
Completion of 
GHQ
Major Depressive 
Episode & scored 
Montgomery-
Åsberg Depression 
Rating Scale 
(MADRS) ≥ 20
Major depression GHQ ≥ 5, + those scoring GHQ 2–4 had 
a 30% probability & those scoring GHQ 
0–1 had an 8% probability of selection. A 
random 50% of those not selected by 
GHQ but whom the GP had identified as 
having psychological problems were also 
selected
Non referred 
patients 
presenting 
with 
impairment 
due to anxiety 
or depression
Measurement 
of depression 
at baseline
SADS - Present State 
Exam (PSE)
SADS-Lifetime 
Version
Clinical 
Interview 
Schedule (CIS)
SCID, Clinical 
Global Impression 
(CGI), MADRS
Composite International Diagnostic 
Interview (CIDI), CES-D
CIDI, Somatic and Psychological Health 
Report (SPHERE)-34
SCID
Cohort (% 
female)
196 (% female not 
stated)
1336 [Data 
presented on 
942 (74% 
female) 
insured 
patients with 
complete 
follow ups]
201 (64%–71% 
across onset 
groups) 
[Includes 20 
participants 
with 
depression 
and 13 with 
borderline 
depression]
247 at first 
interview 
[Paper reports 
only on 166 
followed up 
(54% female)]
305 (74%) 
[305 (74%) 
screened with 
GHQ in cross 
sectional study 
in 1997 
(Kessler et al., 
1999) [52% 
(157/305) 
GHQ +ve at 
screening, not 
clear from 
2002 paper 
how many of 
the 157 were 
found again in 
2002 paper] 
[60]]
492 (72%) 1117 (ranged across sites: 54–71%) 908 (66%) 108 (80%) 
[108 
consecutive 
patients were 
prospectively 
evaluated, the 
paper does 
not state if 
this is the total 
number in 
cohort or 
those retained 
at follow up]B
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Duration of 
follow-up
12 months 6 months 3.5 years 6 months 3 years 6 months 12 months 12 months 8 months 
median follow 
up (Range 1–
72 months)
Other 
comorbidity 
measured
No Yes Yes Yes Yes Yes Yes Yes Yes
Care 
received 
examined
No Yes Yes Yes Yes Yes Yes Yes Yes
Definition of 
depression 
outcome
Loss of key 
symptoms & 
syndromal status + 
return to normal 
functioning for a 
minimum of 2 
months
Not stated No longer met 
criteria for 
baseline 
diagnosis
Remitted 
cases were 
those with 
positive 
SADS-L 
diagnosis at 
baseline but 
not at follow 
up
No longer 
case on GHQ-
12
Symptomatic 
exacerbation 
(MADRS score > 
20) among patients 
who had responded 
to treatment but 
had not yet been 
well for a sufficient 
amount of time 
(under 6 months)
Complete remission from major depression Results not yet available on outcome Not stated
Author Michigan 
Depression 
Project [47, 49]
Parker et al. 
[68]
Ronalds et 
al. [37]
Rost et al. 
[67]
Rost et al. 
[38]
Schulberg et. 
[66]
Wagner et al. [42, 54] WHO Collaborative Project on Psychological 
Problems in General Health Care 
[41,46,53,56,58,69,70]
Location US Australia England US US US US 15 centres in 14 countries [Countries included in the study 
are: India, Turkey, Greece, Germany, The Netherlands 
[55], Nigeria, UK, Japan, France, Brazil, Chile, US [57,70], 
China & Italy [36]
Primary care 
setting/s
Family physicians & 
University of 
Michigan, 
Department of 
Psychiatry 
Outpatient 
Depression Program
12 General 
Practices
One General 
Practice with 
an attached 
psychiatric 
social worker, 
a visiting 
psychiatrist & 
a clinical 
psychologist at 
the health 
centre
21 primary 
care practices
Using 
statewide 
telephone 
screening, 
identified and 
followed a 
cohort with a 
current major 
depression 
who made one 
or more visits 
to a primary 
care physician 
during the six 
months 
following 
baseline
One general medical 
clinic & two family 
practice clinics
One university-based family practice clinic Health centre, primary health care unit, outpatient clinic, 
GP offices & private clinics, family practice, neighbourhood 
hospital & district hospital, primary care clinic
Selection of 
primary care 
setting
Not stated Not stated Not stated Not stated Not stated Not stated Not stated Previous successful WHO collaboration, research 
experience in primary care, access to patient population
Recruitment Waiting room Consecutive 
patients
All surgery 
attenders
Consecutive 
patients
Statewide 
telephone 
screening, 
those who 
were 
depressed 
invited for 
telephone 
interview
Patients completed 
a depression 
screening 
instrument 
presented to them 
by receptionist
Patients introduced to RA by family physician 
at end of clinical visit
Consecutive patients
Screen for 
depression
CES-D Beck 
Depression 
Inventory 
(BDI)
GHQ-28 3-item screen 
for major 
depression & 
dysthymia
Burnam 
screener
CES-D CES-D GHQ-12
Table 1: Methods (Continued)B
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Exclusion 
criteria
Not stated Inadequate 
knowledge of 
English, 
severely 
distressed & 
first time 
attenders
Not meeting 
DSM-III-R 
criteria for 
generalised 
anxiety, panic 
or depressive 
disorder
No access to a 
telephone
Bereaved, 
manic, acutely 
suicidal or 
denied 
depressive 
symptoms
Contact with clinics 
during the six 
months prior to 
index assessment
Being seen by the Duke Student Health 
Service, employees of the Department of 
Community & Family Medicine, or too ill 
physically
< 18 years, > 65 years, too ill, no fixed address, did not 
come for a medical consultation, communication problem, 
no consent
Criteria for 
inclusion in 
cohort
Major depression BDI ≥ 10 Met DSM-III-R 
criteria for 
general 
anxiety, panic 
or depressive 
disorder
Major 
depression
Major 
depression
CES-D ≥ 16 CES-D ≥ 16 + random sample of CES-D <16 Current psychiatric disorder at baseline diagnostic 
assessment & 20% random sample
Measurement 
of depression 
at baseline
SCID, CES-D, 
Hamilton Rating 
Scale for Depression 
(HAM-D)
past & current 
depression, 
PSE, Zung 
Depression 
Scale (ZDS) & 
9 visual 
analogue 
scales
Psychiatric 
Assessment 
Schedule 
(PAS), 
Hamilton 
Depression 
Rating Scale 
(HDRS), 
Clinical 
Anxiety Scale 
(CAS)
Depression 
Outcome 
Module 
(DOS), 
Inventory to 
Diagnose 
Depression 
(IDD)
(Diagnostic 
Interview 
Schedule) DIS
DIS DIS, CES-D CIDI-Primary Health Care, GHQ-28
Cohort (% 
female)
81 from primary 
care (% not stated)
35 (86%) 182 with 
depressive, 
anxiety or 
panic disorder 
[Reports on 
148 (67% 
female) 
followed up]
47 (81%) 162 (% not 
stated)
294 (76%) 213 (range 61–83% across depression 
categories)
1174 (74%)
Duration of 
follow-up
9 months 20 weeks 6 months 5 months 12 months 6 months 12 months 12 months
Other 
comorbidity 
measured
Yes Yes Yes Yes Yes Yes Yes Yes
Care 
received 
examined
Yes Yes Yes Yes Yes Yes Yes Yes
Definition of 
depression 
outcome
Improvement in 
HAM-D score
improvement 
in Zung scores
Change in 
HDRS scores, 
changes in 
CAS scores & 
reduction in 
index of 
definition level
Remission 
from major 
depression
Remission: ≤ 2 
of 9 DIS 
criteria for 
major 
depression 
met within last 
2 weeks.
Resolution of major 
depressive disorder
Improvement i.e. moved to a less severe 
diagnostic category
Presence or absence of a depressive episode
Table 1: Methods (Continued)B
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Table 2: Results
Author Blacker et al. 
[59]
Grembowski et al. [51] Groningen Primary Care 
Study [32-35,50,64,65]
Kessler et al. [61] Kessler et al. 
[45,60]
Limosin et al. [43] Longitudinal investigation of 
depression outcomes in 
primary care (LIDO) [39,40, 
44,52,62]
Retention 72% (142/196) 
[Retention 
calculated from 
data presented in 
paper as not stated 
in results]
71% (942/1336) 77% (154/201) 67% (166/247) 59% (179/305) 
[Paper reports on 
88 of original 157 
GHQ +ve cases 
[60]]
86% (424/492) 87% (968/1117) [Data presented for 
9 month follow up]
Recovery from/
improvement in 
depression
% not stated SCL-20 significantly reduced at 
6 months (1.72 to 0.91, p < 
0.001). Restricted activity days 
due to emotional health 
significantly reduced at 6 
months (6.00 to 2.67 days, p < 
0.001)
32% at 12 months & 47% at 3.5 
years
At 6 months, major depression 
was present in 33% of both the 
new & continuing case groups & 
in 16% of the remitted group
50% (16/32) of 
those not detected 
by a GP at baseline 
or during the 3 year 
follow up
65% (308/476) recovered 
without relapse, 25% (117/
476) developed a chronic 
condition & 11% (51/476) 
relapsed after recovery
35% (340/968) complete remission 
(range 25%–48% across sites) [Data 
presented for 9 month follow up]
Predictors of 
outcome
No data presented No data presented Positive life change increased the 
probability of remission in women 
fourfold (HR = 4.4), but not in 
men. Predictors of faster time to 
remission were low severity of 
pre-morbid difficulties (HR = 0.7), 
high self-esteem (HR = 1.4), and a 
coping style aimed at reducing 
tension (HR = 1.4) [32].
No data presented No data presented History of recurrent major 
depressive disorder was 
associated with a higher 
risk of relapse (OR 1.6, 
95% CI 1.08–3.43)
Education, key life events, & the 
Quality of Life Depression Scale 
score at baseline predicted 
complete remission after adjusting 
for centres, socio-demographic 
data, severity of depression, 
comorbidity & general quality of life 
[52]
Treatment 61% received no 
treatment during 
follow up & 29% 
received 
treatments of a 
type intensity & 
degree that would 
be considered 
"therapeutic"
At follow up, 23% (219/942) of 
patients had been referred & 
38% (356/942) had visited a 
mental health specialist. 54% 
visited a psychologist, 12% a 
psychiatrist & 34% visited both. 
Patients who saw a mental 
health specialist had more visits 
for depression to a primary 
physician than those who did 
not see a mental health 
specialist (1.93 [± SD 2.2] 
vs.0.98 [± SD 1.5]; p < 0.001)
Recognition of psychiatric 
disorder by a GP among new 
cases resulted in greater 
likelihood of referral to a mental 
health specialist (OR 3.0), 
receiving psychotropic 
medications (OR 4.5), having a 
counseling session (OR 12.2) and 
having any mental health 
treatment (OR 6.7) [64].
Patients developing disorders 
between the first & second 
interview had the highest total 
ambulatory use, primary & 
specialty care of all types (9.23) 
[5.95 visits for no diagnosis 
group, 7.53 visits for remitted 
cases & 8.35 visits for continuing 
cases], while patients with 
continuing cases had the highest 
mean number of primary care 
visits (4.54) [3.19 visits for no 
diagnosis group, 3.35 visits for 
remitted cases & 3.28 visits for 
new cases]
68% (38/56) with 
diagnosis, were 
treated with 
antidepressants & 
21% (12/56) were 
referred to 
psychiatric services
All received an 
antidepressant treatment 
during the 6-month period. 
The total duration of 
treatment was <3 months 
for 41%, <30 days for 11%, 
between 30–60 days for 
21%, & between 60–90 days 
for 9%. Duration of 
treatment was between 3–
6 months for 14% of 
patients & ≥ 6 months for 
45% of patients
0% (0%) in St Petersburg to 38% 
(33%) in Seattle received 
antidepressants (an effective dose) 
during follow up. 29% in Melbourne 
to 3% in St Petersburg received any 
specialty mental health care. The 
likelihood of receiving potentially 
effective antidepressant or mental 
health treatment at 3 months or 9 
months did not differ across sites 
between the patients who were in 
complete remission & those who 
were not
Author Mental Health & 
General 
Practice 
Investigation 
(MaGPie) [63]
Manning et al. [48] Michigan Depression Project 
[47, 49]
Parker et al. [68] Ronalds et al. 
[37]
Rost et al. [67] Rost et al. [38]
Retention 83% (753/908), 
77% final magpie 
interview (696/
908)
108 73% (59/81) of primary care 
patients [Data presented for 4.5 
month follow up]
57% (20/35) 81% (148/182), 74 
with major 
depressive disorder 
and 74 with 
generalized anxiety 
or panic disorders
81% (38/47) 94% (152/162) [Paper reports on 98 
patients visiting a primary care 
physician ≥ 1 during 6 months 
following baseline]
Recovery from/
improvement in 
depression
No data presented No data presented Detected primary care patients 
failed to show significant 
improvement in HAM-D scores at 
4.5 months. Both undetected 
primary care & detected 
psychiatric patients showed 
significant improvements over 4.5 
months [By 9 months most 
patients in all 3 groups had 
improved & no longer met 
criteria for MDD [47]]
42.6 at baseline to 40.1 at follow 
up, indicating a 6% improvement
Median HDRS score 
reduced from 12 
(interquartile range 
9–15) at baseline to 
5 five (interquartile 
range 1–10) at 
follow up
32% (12/38) Remission: 36.9% of undetected 
patients and 29.2% of detected 
patients at 12 month follow up. 
Improvement: 10.2% of undetected 
patients and 9.8% of detected 
patients at 12 month follow upB
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Predictors of 
outcome
No data presented No data presented No data presented Baseline predictors of a better 
outcome (improvement) were 
having a history of episodic or 
recurrent episodes; a more 
severe depression; lower social 
class; break up of an intimate 
relationship as a precipitant; a 
neutralizing life event & family 
support
A reduction in social 
difficulties, high 
baseline HDRS 
score, higher 
educational level 
and current 
employment were 
associated with 
greater reduction in 
HDRS scores 
(adjusted R2 = 
33.2%).
Patients who received 
pharmacologic treatment 
concordant with guidelines 
between index visit & 
follow up were more likely 
to be in remission at follow 
up than subjects who did 
not (X2 = 3.8, p < 0.05)
No data presented
Treatment In the year 
preceding the 
index consultation, 
1/3 of male & 42% 
of female patients 
had five or more 
GP consultations
Not purpose of paper In the past 6 months: 75% of 
detected & 9% of non-detected 
primary care patients had been 
prescribed medication, 88% & 
29% respectively had been 
counseled by physician, 56% & 
12% had been referred for 
counseling & 36% & 3% 
respectively had received 
individual or group therapy
At follow up, 2 were still 
receiving antidepressant & 4 
anxiolytic medication, while 3 
were continuing to see their GP 
for depression
In 93 patients the 
psychiatric disorder 
was recognised & 
managed as follows: 
30 patients by 
discussion/
counseling without 
drugs, 26 treated by 
GP with 
psychotropic drugs 
& 37 patients were 
referred to the 
specialist services. 
The greatest 
reduction in 
depression was in 
the patients 
managed without 
psychotropic drugs 
& referred to 
mental health 
services.
63% (24/38) filled 
prescriptions for one or 
more antidepressant 
medications between index 
visit & follow up. 29% (11/
38) received pharmacologic 
treatment concordant with 
AHCPR guidelines. Two 
patients received 3 or more 
counseling sessions from a 
mental health professional.
52% of detected patients had a 
prescription for antidepressant 
medication during the year following 
baseline, 27% completed course in 
accordance with guidelines. 7% of 
detected patients received a referral 
from their primary care physician to 
a mental health specialist in addition 
to receiving a prescription for 
antidepressant medication.
Author Schulberg et. 
[66]
Wagner et al. [42, 54] WHO Collaborative Project 
on Psychological Problems in 
General Health Care [41,46, 
53,56,58,69,70]
WHO Collaborative Project 
on Psychological Problems in 
General Health Care (Italy) 
[36]
WHO 
Collaborative 
Project on 
Psychological 
Problems in 
General Health 
Care (US) [57,71]
WHO Collaborative 
Project on 
Psychological Problems 
in General Health Care 
(Netherlands) [55]
Retention 93% (274/294) 86% (184//213) 62% (729/1174) of patients with 
depressive episode
Recovery from/
improvement in 
depression
71% (12/17) 37% (19/51) of patients with 
major depression at baseline 
were asymptomatic at 12 
months & 56% (37/66) of 
patients with minor depression 
at baseline were asymptomatic 
at 12 months [42]
67% (482/725) Of the 29 participants with 
baseline threshold major 
depression, 21% (n = 7) were 
well at 12 months & 14% (n = 4) 
were subthreshold
At the 12-month 
assessment, 15/50 
(30%) patients 
continued to satisfy 
criteria for major 
depressive disorder, 
4/50 (8%) met 
criteria for minor 
depression, & 31/50 
(62%) did not satisfy 
criteria for any 
depressive disorder
At 12 months, 32% (21/66) 
of patients with a GP 
recognized ICD-10 
diagnosis recovered (50% 
(33/66) improved) & 27% 
(21/79) patients whose 
ICD-10 diagnosis was not 
recognized by a GP 
recovered (47% (37/79) 
improved)
Table 2: Results (Continued)B
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Predictors of 
outcome
Psychiatric status 
at initial 
assessment & the 
number of 
assigned medical 
diagnoses rather 
than the physicians 
recognition & 
treatment of 
depression 
strongly predict 
continued affective 
disorder
Risk for persistent depression 
at 12 months for those with 
major depression at baseline 
was 44% greater in those with 
co-existing anxiety disorder 
(RR 1.44, 95% CI 1.02–2.04 
[42]
Less than 6 years formal 
education, unemployment, 
severity of depression, 
antidepressant use, repeated 
suicidal thoughts & abdominal 
pain as main reason for contacting 
GP were related to depression at 
follow up [41]. Comorbid 
generalised anxiety had a negative 
influence on the long-term course 
of depression in men (OR 2.66) 
but not women (OR = 0.52) [58]. 
At three month follow up, 
recognized patients reported a 
significantly greater reduction in 
GHQ scores than unrecognized 
patients (6.1 vs 4.1, F = 5.33, df = 
1, p = 0.02), however by 12 
month follow up there was no 
difference between recognized 
and unrecognized patients in 
change in GHQ score or change 
in diagnostic status from baseline. 
Patients with unrecognized and/or 
untreated depression showed 
rates of improvement similar to 
those of patients with recognized 
and/or treated depression [46].
Recognition of mental disorder 
by the physician at baseline was 
not associated with an 
improvement of psychopathology 
after 12 months, but was 
associated with an improvement 
in occupational disability & self-
reported disability among 
threshold cases
The likelihood of 
complete remission 
(no depressive 
diagnosis at 12-
month follow-up) 
was 60% (21 of 35) 
for the recognized 
group & 68% (10 of 
15)
Patients whose 
psychological disorder was 
recognized had no better 
outcomes than those 
whose disorder was not 
recognized
Treatment Among the 9 of 13 
patients 
(depression not 
recognized by GP) 
whose depression 
remitted, 5 
received no 
antidepressants, 
one received only 
25 mg of 
Imipramine, 2 
received an anti-
anxiety drug & one 
received sleeping 
medications. 3 
received 
psychiatric 
treatment at a 
psychiatric facility 
during the study 
period
Odds for a visit to a mental 
health specialist or in the 
general medical sector for 
mental health purposes were 
significantly higher for 
respondents with a diagnosis of 
major depression relative to 
respondents with minor 
depression & significantly lower 
again for asymptomatic 
respondents, again relative to 
the minor depression group. In 
multivariate modeling, female 
gender, white race, & higher 
education was associated with 
higher odds of a mental health 
visit [54]
Those depressed at follow-up 
were twice as likely to be taking 
antidepressants (20%) as non-
depressed at follow- up (11%)
Not presented Of patients with 
major depressive 
disorder (n = 64), 
pharmacy records 
showed that a total 
of 36 (56%) received 
antidepressant 
medications at some 
time during the 3 
months following 
screening. Of them, 
28 (78%) received 
dosages within the 
recommended 
ranges & 27 (75%) 
continued to refill 
antidepressant 
prescriptions for at 
least 90 days. Both 
dosage & duration 
of treatment met 
these standards in 
22 (61%) of 36 
cases. Among those 
with major 
depression, 39% 
(23/59) of visited at 
least one specialty 
mental health since 
screening. 66% (39/
59) received some 
treatment during 
the 3 month follow 
up. Likelihood of 
receiving treatment 
was strongly related 
to severity of illness.
Not presented
Table 2: Results (Continued)BMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
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Treatment and health service use
Only one study did not report on the care received by
patients [59]. Two of the sixteen studies that report col-
lecting data on health service use did not report the find-
ings [38,61]. While Kessler et al. [61] reviewed medical
records, their purpose was to determine point recognition
and validate mental disorders given in the context of an
associated physical disorder, not to examine care received.
Rost et al. [38] examined medical, pharmaceutical and
insurance records to determine the detected and undetec-
ted depression during follow-up. Five studies examined
medication use [44,48,63,68,69] and two presented data
on the use of antidepressant medication [51,67]. Seven
studies examined health care/service utilization
[44,49,54,63,66,67,69] and one described use of and
referral to mental health specialists [51]. Parker et al. [68]
examined GP and psychiatric care, and four studies exam-
ined GP treatment [37,45,63,64]. The MaGPie Research
Group [63] also examined barriers to care and patients'
attitudes to their GP. Seven studies asked patients to self
report on the care they received between baseline and fol-
low-up [37,44,51,54,63,66,69], four studies asked the pri-
mary care physician to report on care [43,49,63,64] and
eight reviewed medical records, chart evidence, insurance
records and/or pharmaceutical records
[37,38,45,48,51,63,66,67] [results not mutually exclu-
sive]. Parker et al. [68] collected data on medication, GP
and psychiatric care during follow-up, however they did
not report whether the data were patient self-report, phy-
sician report or a review of records.
Methodological quality of the studies included in the 
review
Many of the studies have methodological limitations,
including small sample sizes (range 35–108 patients at
baseline and 20–59 patients at follow-up) [48,49,67,68]
and small numbers in the cohort with depression [35,66].
Furthermore, Schulberg et al. [66] was the only study to
consider characteristics of the sample screened with the
primary care population to determine whether the study
patients were representative. No study randomly selected
general practices and then approached a random selection
of their patient list to avoid the frequency of attendance
bias present in studies recruiting consecutive patients. Pre-
vious research has highlighted that a high proportion of
eligible patients are missed when recruiting patients from
general practice waiting rooms, thus limiting the general-
isability of the findings [74]. Moreover, only three studies
included a random or representative sample of primary
care physicians [43,63,64], and seven studies recruited
patients from just one centre or general practice
[37,45,48,54,59,61,66]. These methodological limita-
tions must be acknowledged when considering whether
findings from the studies included in this review can be
generalised to primary care populations.
Representativeness of samples to the primary care 
population
Only one study was able to compare characteristics of the
sample screened with the primary care population [66].
Schulberg et al. [66] compared their cohort of patients
with depressive symptoms with the total clinic population
and noted the cohort was younger and had more females
than would be expected from the medical facilities where
the research took place. Rost et al. [38] compared patients
who agreed to take part in the baseline interview with
those patients who were eligible but refused, and reported
no differences in socio-demographic data and clinical
characteristics including the severity of depression, except
that the cohort were younger and more likely to live in
metropolitan areas.
Between 62%–91% of patients were retained in the stud-
ies at 12 months, and 67%–93% at six months (Table 1).
However, as some cohorts included asymptomatic
patients [45,54,61,63,69], the power of some studies to
determine predictors of depression outcomes is limited.
Course of depression
History and duration
Limosin et al. [43] reported that the current episode of
depression was not the first for 38% of the patients in
their study. In that study, the average number of previous
depressive episodes was 2.1 (SD 1.7 episodes; range 1–12)
and the average time reported between the first and cur-
rent depressive episode was 5.9 years (SD 5.8 years; range
0.5 to 30 years).
Only four of the 17 studies provide information on the
chronicity of depressive symptoms [37,43,58,65]. The
mean duration of the current episode of depression varied
across the two studies that reported it. Limosin et al. [43]
reported the average length of the current episode of
depression was 2.8 months (SD 7 months; range 0.5 to 8
years), while in the Groningen Primary Care Study, the
mean episode duration for depressive disorders was 9 to
10 months [65], however the small sample size in the
Groningen study and non-random selection of patients in
both studies limits the generalisability of these findings.
Ronalds  et al. [37] reported a greater improvement in
depressive disorder for patients with a depressive disorder
of less than six months duration compared to patients
with a duration of greater than six months. In the Gronin-
gen Primary Care Study, patients with depression, anxiety
or neurasthenia disorders with a recent onset or exacerba-
tion, were twice as likely to have that disorder recognized
by a GP and to have improved at follow-up, than patients
with chronic psychological disorders [64].BMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
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Recovery
Eight studies have presented data on recovery from major
depressive disorder. Among these, 32% of patients had
recovered at four months [67], 65–71% had recovered at
six months [43,61,66], 35% had recovered at nine
months [52], 32%–67% had recovered at 12 months
[41,42,54,64,69,70] and 47% had recovered at 3.5 years
[35] (Table 2). It is not possible to meaningfully compare
the findings across studies as there was no consistency in
methods, with studies using different instruments for
screening and diagnosis, and different methods of recruit-
ment and administration (clinician administered,
researcher administered or self report) of instruments
(Table 1). Furthermore, four of these studies included
small numbers of patients with depression; Schulberg et
al. [66] followed up 17 patients with major depressive dis-
order, Ormel et al. [35] followed up 20 patients with
depression and 13 with borderline depression, Rost et al.
[67] followed up 38 patients with major depressive disor-
der and Wagner et al. [54] followed up 51 patients with
major depression and 66 with minor depression. There
were three studies with large sample sizes that presented
data on recovery from major depression/depressive disor-
der. In France, Limosin et al. [43] found that 65% (308/
476) of patients with major depressive disorder recovered
without relapse at six months; at nine month follow-up,
the LIDO study [52] conducted in six countries, found
that 35% (340/968) of patients reported complete remis-
sion from major depressive disorder (ranged from 25%–
48% across countries); and in the WHO Collaborative
Project on Psychological Problems in General Health Care
conducted in 14 countries, 67% (482/725) of patients
with depressive episodes recovered at 12 months [41].
Although both the LIDO and WHO studies administered
(different versions of) the CIDI, the results of the studies
are very different. The authors of the LIDO study offer no
explanation for the lower rate of recovery in their study
compared to other studies [52], however these follow-ups
were done at nine and 12 months respectively which may
contribute to the recovery rates.
The interpretation of the findings on recovery is further
complicated when recovery rates are compared for
patients whose depression was detected or undetected
[38,46,49,64,66]. Despite the methodological limitations
of some of the studies presented such as small sample
size; the results suggest there is no difference in depression
outcomes between patients whose depression is recog-
nized or unrecognized. Rost et al. [38] reported that
47.2% of undetected patients and 39% of detected
patients no longer met criteria for major depression at 12
month follow-up. At six month follow-up, Schulberg [66]
found that "psychiatric status at initial assessment and the
number of assigned medical diagnoses rather than the physi-
cian's recognition and treatment of depression strongly predict
continued affective disorder" (p.312), however, only 6.2%
and 2.9% of this cohort had major depressive disorder at
baseline and follow-up respectively. In the WHO Psycho-
logical Problems in General Health Care study conducted
in 14 countries, Simon et al. [46] found that at baseline
recognized patients had significantly higher mean GHQ
scores and were more disabled than unrecognized
patients. At three month follow-up, recognized patients
reported a significantly greater reduction in GHQ scores
than unrecognized patients; however by 12 month fol-
low-up there was no difference between recognized and
unrecognized patients in change in GHQ score or change
in diagnostic status from baseline. The authors conclude
that "recognition and appropriate diagnosis of depression in
primary care is associated with significantly greater short-term
improvement [and] that increasing recognition of depression in
primary care is only a first step toward more appropriate treat-
ment" (p.97). In the Groningen Primary Care Study at 12
month follow-up psychopathology had improved for
75% of patients whose psychological disorder was recog-
nized (n = 100) by a GP compared to 33% of unrecog-
nized patients (n = 79) (p < 0.001) (OR 6.1 for PSE-ID)
[64]. A similar pattern was found with improvement in
social disability: a significantly greater proportion of rec-
ognized patients compared to unrecognized patients
reported improvement at 12 months (56% vs. 24%, p <
0.001) (OR = 4.0). The majority of participants in this
study were 'new' cases (i.e. a psychiatric diagnosis had not
been diagnosed during the 12 months prior to the index
visit) which may explain in part why the results conflict
with the results from the other studies presented.
Relapse rates
Only two studies in the current review presented data on
relapse rates [32,43]. Limosin et al. [43] reported at six
months that 65% (308/476) of patients with major
depressive disorder had recovered without relapse, 25%
(117/476) developed a chronic condition and 11% (51/
476) relapsed after recovery. In the Groningen Primary
Care Study, 93% of depressed patients had remitted from
index episode at 12 months [32] and the relapse
(described as "transition from an asymptomatic state of at
least two months to a state of mental disorder") rate among
depressed patients was 30%, however the cohort included
only 20 participants with major depression. Limosin et al.
[43] found that a history of recurrent major depressive
disorder was associated with a higher risk of relapse at six
months, while Parker et al. [68] found patients with epi-
sodic or recurrent episodes were more likely to improve at
20 weeks than those with other patterns of depression,
however due to this study's small sample size and short
follow-up time (20 weeks) the results should be consid-
ered tentatively.BMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
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Risk factors for the course of major depressive disorder and 
depressive symptoms
Six studies examined the predictors of the course of
depression [32,41-43,52,58,67].
Chronicity of depression
Longer pre-baseline duration of the depressive episode in
the WHO Collaborative Project on Psychological Prob-
lems in General Health Care study was a predictor of a
poor course of depression [58]. Multivariate analysis
reported that among those whose pre-baseline duration
was at least one year compared to those whose pre-base-
line duration was less than three months, the odds of a
poor short-term course of depression (no full recovery
within half a year) were over five times higher (versus
those whose pre-baseline duration was less than three
months) (OR = 5.22, 95% CI 2.45–11.15). The same was
found for long-term outcomes, with those who had a pre-
baseline duration of one year being more likely to report
a poor outcome compared to those whose pre-baseline
duration was less than one year (OR = 3.54, 95% CI 1.67–
7.52). In the Groningen Primary Care study, duration of
index episode was not associated with the occurrence of a
relapse within the 12 month follow-up after remission
[32].
Severity of depression
Wagner et al. [54] found that a greater proportion of
patients with minor depression (56%, 37/66) than major
depression (37%, 19/51) at baseline were asymptomatic
at 12 months. They found that a diagnosis of minor
depression was associated with almost the same degree of
impairment in health status, functional status and disabil-
ity, and psychiatric service utilization as a diagnosis of
major depression. However, 20% (13/66) of patients with
minor depression at baseline met criteria for major
depression at 12 months, while 22% (11/51) of patients
with major depression at baseline met criteria for minor
depression at 12 months. The authors conclude that sub-
threshold depression or the persistence of depressive
symptoms is a risk for developing major depression. In
the Groningen Primary Care Study, 31% of patients with
borderline depression had recovered at 12 months and
70% at 3.5 years [35]. Indeed, the Groningen Primary
Care Study [35] found that partial remission rather than
complete recovery "was the rule and was associated with
residual disability" (p.759). This study also found that
depression had better outcomes than anxiety and mixed
anxiety-depression. At baseline, patients with both anxi-
ety and depression reported the highest symptoms levels
on the Present State Exam. However given the small sam-
ple size with each disorder these results should be inter-
preted with caution.
The data from studies measuring depressive symptoms are
also difficult to compare for similar reasons. Parker et al.
[68] reported a 6% improvement in depressive symptoms
at 20 weeks; and others reported that depressive symp-
toms had significantly reduced at six month follow-up
[37,51]. At four and a half month follow-up, one study
found a significant reduction in depressive symptom
scores among primary care patients whose depression was
not detected compared to no significant reduction in
depressive symptom scores among detected patients [49].
Kessler et al [45] reported that of the 88 patients who met
criteria for a case on the GHQ, 50% (16/32) of those not
detected by a GP at baseline or during the three year fol-
low up, were no longer cases at three year follow-up.
Grembowski et al. [51] and Ronalds et al. [37] retained a
large sample of patients at follow-up, however Grem-
bowski et al. [51] only included insured patients and
therefore their findings are limited to a sample of mainly
middle-class, Caucasian adults with depressive symp-
toms. The other three studies followed up small numbers
of patients and may not have had sufficient power to
determine reduction in depressive symptoms [45,49,68].
There were two studies where improvement in depressive
symptoms was presented [37,68]. Parker et al. [68] found
that baseline predictors of a "better outcome" for the 20
patients with depressive symptoms at baseline who were
followed up for 20 weeks were: having a history of epi-
sodic or recurrent episodes; a more severe depression;
lower social class; break up of an intimate relationship as
a precipitant; a neutralizing life event and family support.
Multivariate analysis conducted by Ronalds et al. [37]
found that at six month follow-up, high baseline depres-
sion score, higher educational level and current employ-
ment were associated with greater reduction in depression
score among patients with major depressive disorder and
generalized anxiety or panic disorders at baseline. The fac-
tors associated with outcome in this study were not
reported for patients with each disorder, therefore it is dif-
ficult to draw any firm conclusions about the factors asso-
ciated with improvement in depression among depressed
patients.
Comorbidity
Gaynes et al. [42] reported that the risk for persistent
depression at 12 months for those with major depression
at baseline was 44% greater in those with co-existing anx-
iety disorder (RR = 1.44, 95% CI 1.02–2.04). In the Gro-
ningen Primary Care Study, half of the patients who
experienced a positive life change remitted within four
months [32], the probability of remission was 2.3 times
higher following positive life change (HR = 2.3). The pos-
itive life change increased the probability of remission in
women fourfold but not in men (HR = 4.4). Multivariate
analysis found that quicker time to remission was associ-BMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
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ated with low severity of pre-morbid difficulties (HR =
0.7), high self-esteem (HR = 1.4), and a coping style
aimed at reducing tension (HR = 1.4).
Treatment
Rost et al. [67] reported that patients with major depres-
sion who received pharmacologic treatment concordant
with guidelines between baseline and five month follow-
up were more likely to be in remission at follow-up than
subjects who did not, however the sample size was small
and of the 38 patients followed up, only 11 received such
treatment. The findings on whether being prescribed anti-
depressants was associated with recovery were conflicting.
Rost et al. [67] reported that patients who received phar-
macologic treatment concordant with guidelines between
index visit and five month follow-up were more likely to
be in remission at follow-up than subjects who did not,
while Barkow et al. [41] found antidepressant use was
related to persisting depression at 12 month follow-up.
The WHO Mental Disorders in General Health Care Study
found that while patients receiving antidepressants
reported significantly less symptoms on the GHQ at three
months than patients receiving sedatives, this was not the
case at 12 months [56]. However the authors highlight
that as the study was not a trial, efficacy of psychoactive
drugs cannot be inferred.
Sex
Despite the majority of patients in the 17 studies being
female, only three studies reported on outcome by sex
[37,41,68]. All three studies reported no difference
between depression outcome for males and females at fol-
low-up. However two of these studies may not have had
sufficient power to detect differences between males and
females [37,68].
Predictors of the course of depression from multivariate analyses
Whilst there are difficulties in comparing results across the
three large scale studies that measured risk factors for per-
sistence or recovery from depression [41,43,52,58], some
conclusions can be drawn. Remission from depression at
nine months was associated with higher level of educa-
tion (OR = 1.06, 95% CI 1.051–1.11), higher quality of
life (OR = 0.94, 95% CI 0.92–0.97) and experiencing key
life events (OR = 0.71, 95% CI 0.66–0.83) in the LIDO
study, after adjusting for centres, socio-demographic data,
severity of depression, co-morbidity and general quality
of life [52]. A significantly greater proportion of patients
whose major depression had remitted at nine month fol-
low-up had medical conditions, dysthymia or anxiety dis-
orders than patients who were not in complete remission.
While the authors found that there was no consistent var-
iable that predicted remission across the six country sites,
they believed this may have been a result of the "modest"
sample size (range in cohort sizes by country 142–185).
In the WHO Collaborative Project on Psychological Prob-
lems in General Health Care study, sustained non-remis-
sion (i.e. presence of a non-remitted or new depression)
at 12 month follow-up was associated with lower levels of
education (0 years versus 11+ years: OR = 3.78, 95% CI
1.83–7.79; 1–5 years versus 11+ years OR = 1.81, 95% CI
1.02–3.19), unemployment (employed versus unem-
ployed: OR = 1.57, 95% CI 1.02–2.43), severity of depres-
sion (severe versus moderate: OR = 3.27, 95% CI 1.91–
5.62), antidepressant use (OR = 1.79, 95% CI 1.06–3.03),
repeated suicidal thoughts ("crossed my mind" versus no
suicidal thoughts) (OR = 1.82, 95% CI 1.14–2.93), and
abdominal pain as main reason for consulting the general
practitioner (OR = 2.30, 95% CI 1.17–4.52) [41]. The
study also reported that patients had a greater probability
of a poor long term course (no recovery over the 12
month follow-up period) if the severity of their depres-
sion was moderate or worse (versus mild) (OR = 3.38,
95% CI 1.49–7.65), their pre-baseline duration was
greater than one year (versus less than one year) (OR =
3.54, 95% CI 1.67–7.52), they did not have a chronic
physical illness (OR = 0.31, 95% CI 0.13–0.73), they had
low social support (versus high/average) (OR = 0.4 5, 95%
CI 0.19–1.07), and they had lower levels of education (≥
13 years versus < 10 years) (OR = 0.18, 95% CI 0.07–0.47)
[58]. A previous episode of depression increased the prob-
ability of chronicity for younger (OR = 3.60, 95% CI
0.92–14.14) but not older (OR = 0.28, 95% CI 0.05–1.45)
patients. They found that among patients with co-morbid
anxiety, depressed women had a smaller probability of
chronicity than depressed men (OR = 0.13, 95% CI 0.04–
0.41) [58]. Limosin et al reported that relapse from
depression was associated with a history of recurrent
major depressive disorder at six month follow-up (OR =
1.6, 95% CI 1.08–3.43) [43].
Risk factors for persistence of depression identified in this
review were: severity and chronicity of the depressive epi-
sode, the presence of suicidal thoughts, antidepressant
use, poorer self-reported quality of life, lower self-
reported social support, experiencing key life events,
lower education level and unemployment.
Treatment and health service use
The proportion of patients receiving antidepressant med-
ication during the study follow-up period ranged from 0%
(St Petersbourg site in Fleck et al. [52]) to 100% [43]
(Table 2). However, the proportion of these patients pre-
scribed antidepressants according to guidelines in the
three studies that reported this, ranged from 27% [38] to
61% [41].
Three studies reported that the likelihood of receiving
treatment was associated with severity of illness
[51,54,71]. In addition, The WHO Mental Disorders inBMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
Page 15 of 18
(page number not for citation purposes)
General Health Care Study found that younger age, being
male and less time since first onset were associated with
not being prescribed psychoactive drugs [56]. Grem-
bowski et al. [51] found that more severe depressive
symptoms at baseline, previously attending a mental
health specialist, more years of education, younger age
and being female were the best predictors of referral and
utilization of a mental health specialist and that managed
care was not associated with a reduced likelihood of refer-
ral to or of visiting a mental health specialist. Another
study found major depression (OR 1.83), female gender
(OR 2.17), white race (OR 2.34), and higher education
(OR 1.21) were associated with higher odds of a mental
health visit in the last four months [54]. The US site of the
WHO Collaborative Project on Psychological Problems in
General Health Care found that participants with higher
symptom severity as measured by the GHQ-28 at base-
line, and more disability, were more likely to receive anti-
depressant medication or use any specialty mental health
services [71]. This study also reported that patients with
anxiety or depressive disorders at baseline had higher
health care costs in the six months prior to baseline (US
$2,390) than patients with sub-threshold (US $1,098) or
no disorders (US $1,397). These cost differences were due
to higher use of general medical services rather than
higher mental health treatment costs [57]. In the Gronin-
gen Primary Care Study, recognition of psychiatric disor-
der by a GP among new cases resulted in greater
likelihood of referral to a mental health specialist (OR
3.0), receiving psychotropic medications (OR 4.5), having
a counseling session (OR 12.2) and having any mental
health treatment (OR 6.7) [64].
Discussion
Understanding the complex interplay between the devel-
opment and persistence of depression over the longer
term, psychological, social and physical factors and the
health service use and treatment patterns is crucial if we
are to plan better models of care to cope with the increas-
ing burden that depression and related disorders is plac-
ing on people experiencing the condition, their social
networks and the health care system.
Despite the growing interest in depression being managed
as a chronic illness in primary care; this review identified
only 17 observational studies of depression in primary
care, most of which have been conducted in Europe or the
US. The striking finding of this review is the small sample
size of many studies, the small numbers in the cohort with
depression and the short length of follow-up. The studies
provide information on the nature and course of depres-
sion for around 7,500 people receiving routine primary
care. Of the 17 studies, nine studies followed almost
3,000 patients from four countries for less than 12
months, six followed almost 4,000 patients from 19 coun-
tries for 12 months, and two followed over 500 patients
from two countries for longer than 12 months. Only five
studies included large sample sizes (greater than 400
patients) [43,44,51,63,69] and only three of them
reported risk factors for the course of depression
[41,43,52,58].
The review aimed to identify risk factors for persistence of
depression that were common across studies. This was dif-
ficult as the factors studied and measurement tools used
varied widely. Few studies included psychiatric, physical
and social risk factors together, thus preventing us from
reporting on the relative importance of each of these.
Based on this review, of the factors studied, it appears that
the severity and chronicity of the depressive episode, the
presence of suicidal thoughts, antidepressant use, comor-
bid physical illness, poorer self-reported quality of life,
lower self-reported social support, negative life events,
lower education level and unemployment are all factors
associated with the persistence of depression.
Several gaps in the studies included in this review have
been identified. In particular there is inconsistency in the
way depression is defined (symptoms or disorders), how
it is measured and the risk factors that are studied. Non-
psychiatric co-morbidities, social and contextual factors
have been poorly explored. Health service use and treat-
ment is not well documented and studies lack patients'
qualitative experience of depression.
The 17 studies can be grouped into two major types; those
that focus on the nature and course of depressive symp-
toms and those that focus on the nature and course of
major depressive disorder. Recent research by Simon et al.
[19] suggests that the more prevalent conditions, such as
minor depression and dysthymia, place a greater burden
on the health care system than the less prevalent major
depression; yet, many studies reviewed focused on indi-
viduals experiencing major depression. The debate regard-
ing use of diagnostic categories versus symptom severity
in research and clinical practice is ongoing [75,76] and
studies that include the capacity to measure both will add
valuable information to assist researchers and clinicians
as we develop future classificatory systems and clinical
guidelines. We urgently need better consistency in the ter-
minology used in reported research as even among studies
including patients with major depression in the cohort,
the terminology used varied across cohorts (Table 1).
The review found that for some, depression is a chronic
and relapsing disorder, with studies reporting recovery
from a major depressive disorder at 12 months for
between one to two thirds of patients. The variation in
recovery across studies may be due in part to the different
methods used in each study, or because people recruitedBMC Family Practice 2007, 8:28 http://www.biomedcentral.com/1471-2296/8/28
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into each cohort differ. As none of the studies recruited a
random sample of patients, the generalisability of find-
ings is problematic.
The studies reviewed highlight the complex and changing
nature of depression as it exists in a primary care sample;
symptoms improve and deteriorate over time (how this
relates to treatments received is difficult to judge) and
patients can oscillate between depression categories.
We are unable to reliably report on relapse rates asonly
two studies report relevant data stating rates of 11% at six
monthsand 30% at 12 months. Establishing reliable esti-
mates ofdepression relapse in the primary care setting
requires follow-up of larger samplesover a longer time
frame.
It is widely reported that women experience depression
about twice as much as men [77], despite this none of the
studies reviewed reported on risk factors for persistence of
depression for males and females separately. Given the
higher prevalence of depression among females, studies
should analyse the results by sex whenever the sample size
allows.
Current guidelines for management of depression in pri-
mary care are constructed for use, in the main, with newly
diagnosed cases of depression that are not complicated by
physical comorbidities and social factors. This review
demonstrates that newly diagnosed cases of depression
are relatively uncommon, that physical comorbidities are
common and that social factors, when studied are associ-
ated with poorer outcomes. Future guidelines should take
into account the findings of the naturalistic studies and
not rely solely upon evidence gathered in randomized
controlled treatment trials.
Conclusion
Naturalistic studies that document the personal experi-
ence, treatment and service use and take account of the
psychological, physical and social factors influencing
depression outcomes are essential for future service plan-
ning. We hope this review will assist others to plan their
studies and enable them to address the methodological
limitations of previous research.
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